📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Effectiveness of 0.05% oxymetazoline (Vicks Sinex Micromist®) nasal spray in the treatment of objective nasal congestion demonstrated to 12 h post-administration by magnetic resonance imaging. (2014)

First Author: Pritchard S

Attributed to: Genetic and molecular characterisation of sodium reabsorption by thiazide-sensitive pathways in the kidney funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.pupt.2013.08.002

PubMed Identifier: 23988443

Publication URI: http://europepmc.org/abstract/MED/23988443

Type: Journal Article/Review

Volume: 27

Parent Publication: Pulmonary pharmacology & therapeutics

Issue: 1

ISSN: 1094-5539